Long-term Follow-up Durability (Efficacy) Study of EN3835 for the Treatment of AC of the Shoulder (Frozen Shoulder)

TerminatedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

December 17, 2020

Primary Completion Date

September 12, 2022

Study Completion Date

September 12, 2022

Conditions
Adhesive CapsulitisFrozen Shoulder
Interventions
DRUG

Previously treated with EN3835 up to 1.74 mg or Placebo in EN3835-210 or the pivotal phase 3 studies

No treatment to be administered - Observational only

Trial Locations (30)

11794

Endo Clinical Trial Site #10, Stony Brook

15701

Endo Clinical Trial Site #12, Indiana

16602

Endo Clinical Trial Site #30, Altoona

16801

Endo Clinical Trial Site #5, State College

24541

Endo Clinical Trial Site #3, Danville

27704

Endo Clinical Trial Site #29, Durham

30043

Endo Clinical Trial Site #20, Lawrenceville

30265

Endo Clinical Trial Site #21, Newnan

30281

Endo Clinical Trial Site #24, Stockbridge

30720

Endo Clinical Trial Site #26, Dalton

32789

Endo Clinical Trial Site #4, Winter Park

33318

Endo Clinical Trial Site #19, Fort Lauderdale

33606

Endo Clinical Trial Site #1, Tampa

33765

Endo Clinical Trial Site #2, Clearwater

35243

Endo Clinical Trial Site #16, Birmingham

36609

Endo Clinical Trial Site #9, Mobile

45432

Endo Clinical Trial Site #13, Dayton

60523

Endo Clinical Trial Site #23, Oak Brook

Endo Clinical Trial Site #28, Oak Brook

75075

Endo Clinical Trial Site #15, Plano

75093

Endo Clinical Trial Site #18, Plano

76021

Endo Clinical Trial Site #6, Bedford

77401

Endo Clinical Trial Site #17, Bellaire

78041

Endo Clinical Trial Site #22, Laredo

78628

Endo Clinical Trial Site #27, Georgetown

85712

Endo Clinical Trial Site #25, Tucson

91105

Endo Clinical Trial Site #11, Pasadena

91942

Endo Clinical Trial Site #14, La Mesa

92024

Endo Clinical Trial Site #8, Encinitas

92647

Endo Clinical Trial Site #7, Huntington Beach

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY